发明名称 Integrated insulin delivery system with continuous glucose sensor
摘要 Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.
申请公布号 US9586004(B2) 申请公布日期 2017.03.07
申请号 US201314063937 申请日期 2013.10.25
申请人 DexCom, Inc. 发明人 Dobbles John Michael;Kamath Apurv Ullas;Mahalingam Aarthi;Brauker James H.
分类号 A61M5/172;A61B5/145;A61M5/142;G06F19/00;A61B5/00;A61M5/00;A61M5/178;A61M5/30;A61M11/00;A61M15/00 主分类号 A61M5/172
代理机构 Knobbe Martens Olson & Bear, LLP 代理人 Knobbe Martens Olson & Bear, LLP
主权项 1. A method for diabetes management, the method comprising: receiving sensor data generated by a continuous glucose monitoring device, wherein the sensor data is indicative of glucose concentration; calculating an insulin therapy instruction based on the sensor data, using a controller module of a processor; comparing the determined insulin therapy instruction to one or more criteria; constraining the determined insulin therapy instruction if the insulin therapy instruction fails the one or more criteria; and providing the constrained insulin therapy instruction if the insulin therapy instruction fails the one or more criteria wherein the one or more criteria comprises a predetermined basal profile comprising a schedule of one or more time blocks, wherein each time block is associated with a maximum insulin delivery rate.
地址 San Diego CA US